Publications
Found 1 results
Filters: Author is U. Chuensumran [Clear All Filters]
“Association of HTTLPR and 5-HT2A T102C polymorphisms with smoking characteristics and anthropometric profiles of Thai males”, vol. 11, pp. 4360-4369, 2012.
, Abdolmaleky HM, Faraone SV, Glatt SJ and Tsuang MT (2004). Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr. Res. 67: 53-62.
http://dx.doi.org/10.1016/S0920-9964(03)00183-X
Barnes NM and Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083- 1152.
http://dx.doi.org/10.1016/S0028-3908(99)00010-6
Batra V, Patkar AA, Berrettini WH, Weinstein SP, et al. (2003). The genetic determinants of smoking. Chest 123: 1730- 1739.
http://dx.doi.org/10.1378/chest.123.5.1730
PMid:12740294
Chen K, Yang W, Grimsby J and Shih JC (1992). The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Brain Res. Mol. Brain Res. 14: 20-26.
http://dx.doi.org/10.1016/0169-328X(92)90005-V
Chu SL, Xiao D, Wang C and Jing H (2009). Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males. Chin. Med. J. 122: 1365-1368.
Coto E, Reguero JR, Alvarez V, Morales B, et al. (2003). 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clin. Sci. 104: 241-245.
http://dx.doi.org/10.1042/CS20020246
PMid:12605580
Currie PJ and Coscina DV (1998). 5-Hydroxytryptaminergic receptor agonists: effects on neuropeptide Y potentiation of feeding and respiratory quotient. Brain Res. 803: 212-217.
http://dx.doi.org/10.1016/S0006-8993(98)00643-X
Degiampietro P, Peheim E, Drew D, Graf H, et al. (1987). Determination of thiocyanate in plasma and saliva without deproteinisation and its validation as a smoking parameter. J. Clin. Chem. Clin. Biochem. 25: 711-717.
PMid:3694128
do Prado-Lima PA, Chatkin JM, Taufer M, Oliveira G, et al. (2004). Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addiction. Am. J. Med. Genet. B Neuropsychiatr. Genet. 128B: 90-93.
http://dx.doi.org/10.1002/ajmg.b.30004
PMid:15211639
Ebdrup BH, Rasmussen H, Arnt J and Glenthoj B (2011). Serotonin 2A receptor antagonists for treatment of schizophrenia. Expert. Opin. Investig. Drugs 20: 1211-1223.
http://dx.doi.org/10.1517/13543784.2011.601738
PMid:21740279
Erritzoe D, Frokjaer VG, Haugbol S, Marner L, et al. (2009). Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage 46: 23-30.
http://dx.doi.org/10.1016/j.neuroimage.2009.01.050
PMid:19457377
Gerra G, Garofano L, Zaimovic A, Moi G, et al. (2005). Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am. J. Med. Genet. B Neuropsychiatr. Genet. 135B: 73-78.
http://dx.doi.org/10.1002/ajmg.b.30173
PMid:15806583
Greenberg BD, Tolliver TJ, Huang SJ, Li Q, et al. (1999). Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 88: 83-87.
http://dx.doi.org/10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0
Heils A, Teufel A, Petri S, Stober G, et al. (1996). Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66: 2621-2624.
http://dx.doi.org/10.1046/j.1471-4159.1996.66062621.x
PMid:8632190
Heils A, Mossner R and Lesch KP (1997). The human serotonin transporter gene polymorphism--basic research and clinical implications. J. Neural Transm. 104: 1005-1014.
http://dx.doi.org/10.1007/BF01273314
PMid:9503253
Huang S, Cook DG, Hinks LJ, Chen XH, et al. (2005). CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. Pharmacogenet. Genomics 15: 839-850.
http://dx.doi.org/10.1097/01213011-200512000-00002
PMid:16272956
Hwu HG and Chen CH (2000). Association of 5HT2A receptor gene polymorphism and alcohol abuse with behavior problems. Am. J. Med. Genet. 96: 797-800.
http://dx.doi.org/10.1002/1096-8628(20001204)96:6<797::AID-AJMG20>3.0.CO;2-K
Iordanidou M, Tavridou A, Petridis I, Kyroglou S, et al. (2010). Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians. Drug Alcohol Depend. 108: 70-76.
http://dx.doi.org/10.1016/j.drugalcdep.2009.11.015
PMid:20060656
Ishikawa H, Ohtsuki T, Ishiguro H, Yamakawa-Kobayashi K, et al. (1999). Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol. Biomarkers Prev. 8: 831-833.
PMid:10498403
Kato M, Zanardi R, Rossini D, De Ronchi D, et al. (2009). 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients. Psychiatry Res. 167: 97-105.
http://dx.doi.org/10.1016/j.psychres.2007.12.012
PMid:19361869
Keltikangas-Jarvinen L and Salo J (2009). Dopamine and serotonin systems modify environmental effects on human behavior: a review. Scand. J. Psychol. 50: 574-582.
http://dx.doi.org/10.1111/j.1467-9450.2009.00785.x
PMid:19930256
Lane HY, Liu YC, Huang CL, Chang YC, et al. (2006). Risperidone-related weight gain: genetic and nongenetic predictors. J. Clin. Psychopharmacol. 26: 128-134.
http://dx.doi.org/10.1097/01.jcp.0000203196.65710.2b
PMid:16633140
Lerman C, Shields PG, Audrain J, Main D, et al. (1998). The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol. Biomarkers Prev. 7: 253-255.
PMid:9521442
Lerman C, Caporaso NE, Audrain J, Main D, et al. (2000). Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol. Psychiatry 5: 189-192.
http://dx.doi.org/10.1038/sj.mp.4000672
PMid:10822347
Lesch KP, Bengel D, Heils A, Sabol SZ, et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531.
http://dx.doi.org/10.1126/science.274.5292.1527
PMid:8929413
Li MD, Cheng R, Ma JZ and Swan GE (2003). A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98: 23-31.
http://dx.doi.org/10.1046/j.1360-0443.2003.00295.x
PMid:12492752
Mihailescu S, Palomero-Rivero M, Meade-Huerta P, Maza-Flores A, et al. (1998). Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur. J. Pharmacol. 360: 31-36.
http://dx.doi.org/10.1016/S0014-2999(98)00658-X
Munafo MR, Johnstone EC, Wileyto EP, Shields PG, et al. (2006). Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol. Biomarkers Prev. 15: 398-400.
http://dx.doi.org/10.1158/1055-9965.EPI-05-0648
PMid:16492936
Murphy DL, Lerner A, Rudnick G and Lesch KP (2004). Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol. Interv. 4: 109-123.
http://dx.doi.org/10.1124/mi.4.2.8
PMid:15087484
Polesskaya OO and Sokolov BP (2002). Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J. Neurosci. Res. 67: 812-822.
http://dx.doi.org/10.1002/jnr.10173
PMid:11891796
Polina ER, Contini V, Hutz MH and Bau CH (2009). The serotonin 2A receptor gene in alcohol dependence and tobacco smoking. Drug Alcohol Depend. 101: 128-131.
http://dx.doi.org/10.1016/j.drugalcdep.2008.11.001
PMid:19111403
Rosmond R, Bouchard C and Björntorp P (2002). 5-HT2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol. Obes. Res. 10: 585-589.
http://dx.doi.org/10.1038/oby.2002.79
PMid:12105278
Terayama H, Itoh M, Fukunishi I and Iwahashi K (2004). The serotonin-2A receptor polymorphism and smoking behavior in Japan. Psychiatr. Genet. 14: 195-197.
http://dx.doi.org/10.1097/00041444-200412000-00005
PMid:15564892
Turecki G, Briere R, Dewar K, Antonetti T, et al. (1999). Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am. J. Psychiatry 156: 1456-1458.
PMid:10484964
Tyndale RF (2003). Genetics of alcohol and tobacco use in humans. Ann. Med. 35: 94-121.
http://dx.doi.org/10.1080/07853890310010014
PMid:12795339
Vink JM, Smit AB, de Geus EJ, Sullivan P, et al. (2009). Genome-wide association study of smoking initiation and current smoking. Am. J. Hum. Genet. 84: 367-379.
http://dx.doi.org/10.1016/j.ajhg.2009.02.001
PMid:19268276 PMCid:2667987
White MJ, Young RM, Morris CP and Lawford BR (2011). Cigarette smoking in young adults: the influence of the HTR2A T102C polymorphism and punishment sensitivity. Drug Alcohol Depend. 114: 140-146.
PMid:21035274
Yonan AL, Palmer AA and Gilliam TC (2006). Hardy-Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism. Psychiatr. Genet. 16: 31-34.
http://dx.doi.org/10.1097/01.ypg.0000174393.79883.05
PMid:16395127
Zaniewska M, McCreary AC, Wydra K and Filip M (2010). Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal. Neuropharmacology 58: 1140-1146.
http://dx.doi.org/10.1016/j.neuropharm.2010.02.006
PMid:20153341
Zeidler R, Albermann K and Lang S (2007). Nicotine and apoptosis. Apoptosis 12: 1927-1943.
http://dx.doi.org/10.1007/s10495-007-0102-8
PMid:17846896